Supplementary Tables 1 - 2 from A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, As First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
openalex(2023)
关键词
Treatment
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要